Year over Year Revenue Growth Exceeds 463%
Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended
The Company continues making progress on international sales. Our sales partner in
The Research and Development team is expanding its efforts regarding the brain stimulation project by collaborating with the
Two major lenders continue to neither collect nor accrue interest on their notes and no additional stock was issued during the 3rd quarter. It is likely, but not certain, that these lenders will continue to forgo interest at least through the 2nd quarter of 2022 to help offset increased supply and shipping costs caused by global shortages due to the pandemic.
The team at BioElectronics is looking forward to continuing to improve the financial health of the Company and the resulting increase in shareholder value.
About BioElectronics:
Disclosure Certain information set forth in this email contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vii) renewal of the Company’s current customer, supplier and other material agreements; and (viii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.
Although forward-looking statements contained in this email are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
Contact:
pknopick@eandecommunications.com
940.262.3584
Source:
2021 GlobeNewswire, Inc., source